Grimes & Company’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.89M Buy
7,964
+520
+7% +$108K 0.04% 203
2026
Q1
$1.57M Buy
7,444
+667
+10% +$144K 0.04% 197
2025
Q4
$1.39M Buy
6,777
+1,585
+31% +$298K 0.03% 219
2025
Q3
$815K Buy
+5,192
New +$802K 0.02% 249
2020
Q1
Sell
-38,666
Closed -$1.96M 235
2019
Q4
$1.96M Buy
38,666
+1,546
+4% +$79.9K 0.13% 103
2019
Q3
$1.75M Buy
37,120
+3,751
+11% +$171K 0.12% 100
2019
Q2
$1.57M Buy
33,369
+18,981
+132% +$876K 0.12% 103
2019
Q1
$693K Buy
14,388
+3,825
+36% +$192K 0.05% 135
2018
Q4
$471K Sell
10,563
-7,723
-42% -$403K 0.05% 151
2018
Q3
$987K Sell
18,286
-2,840
-13% -$145K 0.08% 119
2018
Q2
$1.03M Sell
21,126
-380
-2% -$21.5K 0.09% 118
2018
Q1
$1.35M Buy
21,506
+658
+3% +$45.1K 0.13% 106
2017
Q4
$1.28M Sell
20,848
-3,017
-13% -$187K 0.12% 102
2017
Q3
$1.6M Sell
23,865
-23
-0.1% -$1.63K 0.17% 90
2017
Q2
$1.86M Sell
23,888
-1,169
-5% -$88.2K 0.21% 88
2017
Q1
$2.04M Sell
25,057
-50,885
-67% -$4.01M 0.22% 81
2016
Q4
$5.47M Sell
75,942
-3,488
-4% -$252K 0.63% 45
2016
Q3
$6.17M Buy
+79,430
New +$6.42M 0.83% 35

Other funds holding CAH

Grimes & Company's CAH Position: Q2 2026 in Review

Grimes & Company increased its Cardinal Health (CAH) stake by 7% in Q2 2026, buying an estimated $108K and bringing the position to 7,964 shares worth $1.89M. The position accounts for 0.04% of the portfolio, ranked #203.

Grimes & Company first reported a position in CAH in Q3 2016 and has held it in 18 quarters since. The position peaked at $6.17M in Q3 2016. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Grimes & Company held 7,964 shares of Cardinal Health worth $1.89M as of Q2 2026.
  • Grimes & Company bought 520 Cardinal Health shares in Q2 2026, an estimated $108K.
  • Cardinal Health made up 0.04% of Grimes & Company's portfolio in Q2 2026, its #203 holding.
  • Grimes & Company first reported a position in Cardinal Health in Q3 2016 and has held it in 18 quarters since.
  • Grimes & Company's Cardinal Health position peaked at $6.17M in Q3 2016.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.